chrisvoncsefalvay/vaers-outcomes huggingface dataset:
*Right after administration of vaccine, tingling, swimming feeling throughout body. Mouth tingling *Waited 15 minutes, felt ok. *Got to car from vaccine site, heart started racing *That night, tightness in chest, Lt side, w/breathing in. Heart rate in 80's, seemed regular *Next day, Wed 3/24/21, felt groggy,  chest tightness, pain when breathing in or leaning forward *Thursday 3/25, continued w/intermitt chest tightness and pain. weird feeling of Shortness of breath/needing to take a deep breath. *Appointment at Cardiology, nurse visit/EKG, and met with Dr. (3/26/2021) Per Dr., diagnosed with pericarditis. Instructed to take 800mg Ibuprofen, four times a day and Vitamin C, avoid overheating and exertion. *Chest discomfort continued intermitt. through Sunday 3/28/2021 *Sunday 3/28/2021 - throbbing headache x2 days *By Saturday, 4/3/2021, chest tightness/pain seemed to be resolved.
Fever. Chills. Dizziness. Hip Pain. Flank Pain. Joint Pain. Headache. Shivering. Nausea. Diarrhea. Weakness. Fatigue. Times 3 days
arm was sore & became red & swollen;put on antibiotics, APAP & to apply hot packs
Red bumps severe itching open wounds everything 0tc did not work went to the dermatologist and got prescription creams and ointments and those do not work.
I started having high blood in November 2021 or December 2021. I caught COVID in January 2022. My blood pressure seemed to be going up even more. It felt like I had the flu or a sinus infection. I have been very fatigued after I had the COVID and COVID vaccines. On March 16, 2022, I woke up in the middle of the night. My legs were feeling heavy. I got up later and I was unsteady on my feet. I couldn't speak well. I called 911 and the ambulance took me to the ER. I was hospitalized for 3 days. The doctor said I had a mini stroke. They ran test to see why that happened, but they didn't find anything wrong with my heart, arteries, or anything like that. I went to a neurologist, and they sent me to see a cardiologist. I will be wearing a heart monitor for a month sometime in May 2022. I was prescribed Atorvastatin 40mg, Aspirin to take in the morning, and the doctor upped my Lisinopril dosage to 20mg. I am still in the process of going to see some specialists. The doctors are still trying to figure out what caused the mini stroke.
Symptoms previously not associated together (skin rash and kidney problems) suddenly match very well those described in the EU investigation of mRNA Covid-19 vaccines. They match perfectly in time (beginning January circa first Moderna shot, accelerating after second). Skin rash consistent with erythema multiforme in appearance, progression and characteristics. Bilateral kidney pain and rapid otherwise unexplained deterioration of kidney function.
A red mark at the injection site about a week after the injection. Oval shaped, itchy, and sore
following vax pt fainted in restroom; it is not known if hit head on the door frame or floor but there was no swelling or bleeding; LOC for 20 sec w/full recovery;
Moderna Covid - 19 Vaccine EUA I received the vaccine on Wednesday January 6th. EARLY Friday morning around 30 minutes after midnight - I noticed pain on my left shoulder / neck area (tenderness). I began to feel around and found a swollen lymph node at the base of my neck just inside my left collar bone. Seems to be the supraclavical lymphnodes. I also noticed tenderness under my left arm in the arm pit region. I received the injection on the left side.
left ring finger burning, swelling, redness was reported as worsened.; left ring finger burning; Swelling; Redness; states specifically the hive is between her ring and middle finger; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection ), via an unspecified route of administration, administered in the left arm on 24Feb2021 at 12:15 (at the age of 71-years-old) (Lot Number: N96200) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously took the first dose of BNT162B2 (Lot Number: EL3246) on 03Feb2021 at 12:14 for COVID-19 immunisation. On 24Feb2021, the patient experienced left ring finger burning, swelling, redness and stated specifically the hive is between her ring and middle finger. It was reported on an unspecified date left ring finger burning, swelling, redness worsened. The outcome of the events burning sensation, swelling, erythema, and urticaria was not recovered/not resolved. Outcome of the event condition aggravated was unknown.  No follow up attempts are possible. No further information is expected.
This case was considered medically important. Information regarding Dryvax was received from a consumer, regarding a female patient (age unknown) who experienced a severe allergic reaction. The patient received a dose on an unspecified date. The patient experienced a severe allergic reaction on an unspecified date. No further information was provided.
an adult dose of Havrix was administered to a child; an adult dose of Havrix was administered to a child; This non-serious case was reported by a nurse via call center representative and described the occurrence of overdose in a 12-month-old male patient who received HAV (Havrix 1440 adult) (batch number 772YT, expiry date 23-SEP-2025) for prophylaxis.   On 31-OCT-2023, the patient received the 1st dose of Havrix 1440 adult. On 31-OCT-2023, an unknown time after receiving Havrix 1440 adult, the patient experienced overdose (Verbatim: an adult dose of Havrix was administered to a child) and adult product administered to child (Verbatim: an adult dose of Havrix was administered to a child). The outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-NOV-2023 Nurse reported that an adult dose of Havrix was administered to a child, which led to overdose and adult product administered to child. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal.
Rash on (L) arm x 12/26/10. Zoster in C6 dermatome in left arm where vaccine given 6/11/08.
pt recv vax & exp flushing & nausea for about 2 hr;pt recovered from flushing & nausea;
We had given a pediatric Pfizer vaccine on Saturday and had left vaccine vial in refrigerator in case another patient needed a dose. Patient presented for Moderna booster on Monday and was inadvertently given a dose out of this pediatric Pfizer vial (0.25 ml). When realized, we contacted patient, who returned to receive correct Moderna booster. No adverse effects known at this time.
Information has been received from a 73 year old female patient with blood pressure high and sulfonamide allergy who in October 2007, was vaccinated with ZOSTAVAX (Merck), SC. Concomitant therapy included AZOR. The patient stated that starting in March, 2008 she had a zit on her waist line that kept growing and got infected. Since the zit was infected the patient had to get it drained and was in the hospital for a couple of days. The consumer reported that not to long after that she had another zit on her lip area that went up her nose which kept growing and got infected again. The patient then went to the hospital again for two and a half days and had the zit drained and was put on vancomycin (manufacturer unspecified). The patient reported that her physician thought that what she had was either Mersa or staph infection, but she did not believe that was what she had. After leaving the hospital the patient was put on another medication (name, description and manufacturer unspecified), she started to experience severe chest pain, her blood pressure and heart rate went up and was sent to the hospital, and was there for three days. When she was at the hospital she had blood work done which showed she had a slight heart attack and when she had a stress test. The consumer reported that she still was getting the zits but they have not got as bad as they were the first two times." No further information is available.
Pt presented to the ED after suffering a fall, complains of dehydration, nausea, vomiting,high heart rate, and SOB for 2 days.  Daughter whom she lives with had tested positive for COVID,  -EKG on admission showed atrial fibrillation with RVR, independently reviewed.  Troponin 34, BNP 11182.  Chest x-ray showed nonspecific patchy bibasilar interstitial and airspace opacities, independently reviewed.  CT of the abdomen and pelvis without contrast on 01/15/2022 showed no acute abnormality, calcific atherosclerotic disease, severe stenosis at the origin of the superior mesenteric artery unchanged, no evidence of bowel ischemia, diverticulosis, cholelithiasis, ...  -Lasix IV b.i.d. strict intake and output, daily weights, cardiac diet, fluid restriction. will obtain a 2D echo and consult Cardiology.  Aspirin, statin. serial troponins and EKGs.  Lipid panel, TSH, HbA1c.  Morphine and sublingual nitroglycerin as needed for chest pain.    -amiodarone drip for rate control for atrial fibrillation.  Continue with Eliquis for anticoagulation.    -white count is 9, currently afebrile, blood pressure is acceptable, sepsis focused exam performed.  Sirs criteria positive including tachycardia and tachypnea.  Appropriate IV hydration given in the emergency room.  Avoid IV hydration due to volume overload and CHF.  Blood cultures done in the emergency room.  Lactic acid 1.3.  Atrovent inhaler around the clock, Robitussin DM as needed for cough, incentive spirometry, Decadron 6 mg IV daily for 10 days.  Consult pulmonology.  Patient with severe pulmonary hypertension and recurrent admission forearm interstitial lung disease.    -COVID-19 test is positive 1/16/22.   Pt vaccinated with Moderna 3/21/21 & 4/18/21. Patient discharged 1/21/22.
swelling from the inj site to the neck about 1/2hr p/vax; lasted about 1 1/2hr & resolved;was not associated w/any rash, facial swelling, hypotension or dyspnea;
A bump at the site of administration of the vaccine; A 3 inch rash at the site of administration of the vaccine; This spontaneous case from  was received on 24-Sep-2020 from other non-health professional via The Agency (reference number: SEQW20-02263) and concerned a patient of an unknown age and gender.  The patient's medical history and concomitant medications were not reported.   On 17-Sep-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) for influenza prophylaxis. The batch number reported was 283849, expiry date: 30-Jun-2021.   On the same day, after receiving Flucelvax QIV, the patient developed a bump and a 3-inch rash at the site of administration of the vaccine.  On an unspecified date in Sep-2020, the patient recovered from the events.  The reporter did not provide a causality assessment.   The case was assessed as non-serious.  This case is linked with cases: 202004696, 202004698, 202004699, 202004706, 202004701, 202004702, 202004703, 202004704, 202004705, 202004678, and 202004700 (same reporter).  Additional non-significant information received on 06-Jan-2021 from other non-health professional via The Agency (reference number: SEQW21-00065) with additional information received on 12-Jan-2021 from other health professional (reference number: SEQW21-00149) (being processed together): Two additional reporters added. Reference numbers added. No changes in narrative.  Company comment: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).
HCP caller is complaining of a fever after vaccine got wed; Chills; felt tired; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient started to received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date: 31Mar2021), via an unspecified route of administration on 16Dec2020 at a single dose for Covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. The patient called to report on the COVID vaccine, and explains that she received the vaccine on Wednesday, 16Dec2020 around 2:30pm. She received the vaccine at work. It was administered in the left upper arm. The following morning (17Dec2020) around 2am she woke up with chills and a fever that lasted all day yesterday, so she didn't go to work. She was running a fever of about 99.7-100.0 on 17Dec2020 and that was with alternating Advil and Tylenol. She felt tired and so she rested the whole day. The patient explained that she thought it would go away after a day but today she woke up at 5am with chills. She didn't take her temperature at that time but took some medication. Then on 18Dec2020 at 9am, she woke up with chills again and she still was at 100.8. She called to see how long does the fever last after the vaccine. Outcome of the events fever and chills was not recovered and for fatigue was unknown.
6/20: 4mm small red singular lesion on left thigh area near ending of underwear . size started getting larger over few days  like a football shape. width: 6-7mm. not itchy. flat. red.   6/24 - started seeing small 1-2mm red spots on both legs, not raised and were flat. no pain, no itchiness.  6/25 - these red spots have also formed all over body 1-4mm sized - legs, torso, butt, arms, side of my body under arm. Still Flat.  6/26 - Started noticing these spots on my BODY were starting to become more "raised" and defined. LEGS were still flat. 6/27 - same as 26th 6/28 - LOWER TORSO AREA where waistband of pants go - spots are defined and ITCHY. First time. 1mm - flat // 3-4mm spots raised - like a mosquito bite 6/30 - lesions spread across arms and side of body near breasts. rashes mostly severe around waist and pubic area and thighs
This spontaneous report was received from a registered nurse refers to a 22 year old females patients. On an unknown date the patient was vaccinated with M-M-R II (dose, lot # and route of administration was not reported). It was reported that patient had titers for M-M-R  drawn on unknown date and the titers came back to negative. The reporter stated that the patient was revaccinated with M-M-R II on unknown date because of this. The outcome of titers came back negative was unknown. Additional information has been requested.
Menstrual period was 3 days early, cramping everyday and period was 14 days long. Periods are normally on time and last only 7-8 days. cramping usually only for the first 3 days.
Got positive reading after her vaccination.; Got positive reading after her vaccination.; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two patients (herself and her husband). This is first (wife) of two reports. A female patient of an unspecified age received her first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that got positive reading after her vaccination on an unspecified date. She added that her husband got a bad covid outbreak after first dose and the location closed. The patient underwent lab tests and procedures which included covid-19 reading (sars-cov-2 test) was positive on an unspecified date. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
It is 5:15 AM on 09/20/2018 and I have been awake for most of the night - unable to sleep - like my brain is wide awake and racing and won't go to sleep. I tried 3 different sleeping areas, sleep hypnosis, relaxation meditation, and I am still wide awake. I am supposed to be to work at 8:00 AM which includes a 45 minute drive - which I am uncomfortable doing since I don't know when the tiredness is going to kick in today. This episode reminds me of a time I took prednisone in the later hours of the day. No one advised me that it would keep me up all night - but it did!
This spontaneous report refers to a 58 year old female patient. The patient's medical history included shingles. Physician called and stated that she had administered ZOSTAVAX to an unspecified 58 year old female patient that had a prior history of shingles, on November 2013 on an unspecified day. The patient developed a case of shingles on December 2013 on an unspecified day. The patient was recovered from the case of shingles on an unspecified date. Patient stated that she had quite a bit of pain in addition to the herpetic rash. The patient sought medical attention. The rash was only in a small concentrated area on an unspecified part of the patient's body. Patient also stated that the rash lasted a much shorter duration than in the past, prior to receiving ZOSTAVAX. Additional information has been requested.
I tested positive w/ a home test and called my doctor and tested positive on a PCR test.  I had a cough and a slight runny nose.  I was prescribed Paxlovid which I finished and tested negative for the following 3 days.  Tested positive again after that but no symptoms except for a slight cough.
The initial symptoms exp stomach cramping. Then on  12/31 I started exp pain in lower back felt like muscle spasm. I went to ER got Chest Xray,Flu (results negative)and Covid test (result positive).
SPANISH SPEAKING REPORTER: I had headache with both vaccines but after 2 weeks from taking the 2nd vaccine I started to experience extreme tiredness and unable to stay awake at work and while talking to other people, and on 9/25 I felt even worse, with body shakes, dizziness and unable to drink fluids without it running out of the left side of my mouth, when one of my daughters stopped by later that day she noticed I didn't look well and insisted in taking me to the hospital ER.
Several episodes of itching, wide spread hives, syncope, and vomiting beginning approximately 5 days after 3rd vaccine.
pt recvd vax; exp itchyness, reddish papules over upper arm around inject site x few hrs, but resolved;malaise,fatigue,aches still persist;
Site is red, warm, hard, swollen, sore. Site measures 4" by 3 1/2".  Treatment: KEFLEX 500 mg 1 by mouth twice a day for 7 days and MOTRIN 800 mg twice a day as needed.
This spontaneous report as received from a registered pharmacist refers to a male patient of unknown age, who on an unknown date, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number were not reported). No other co-suspects were reported. No concomitant medications were reported. The registered pharmacist reported that on an unspecified date the patient had a nodule, location was unspecified. At the time of the report, the patient's outcome for the adverse event was unknown. The relatedness for the adverse event was unknown for ZOSTAVAX. Additional information has been requested.
medication error due to temperature excursion that exceeded the stability data and FLUZONE QUADRIVALENT multidose vial was administered to patient, with no reported adverse event; medication error due to temperature excursion that exceeded the stability data and FLUZONE QUADRIVALENT multidose vial was administered to patient, with no reported adverse event; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional (hcp).  This case involves a 43-year-old (unknown gender) patient, reported a medication error due to temperature excursion that exceeded the stability data and INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [Fluzone Quadrivalent Multidose] vial was administered to patient, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 22-Sep-2022, the patient received suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (strength, formulation, dose , route: unknown) (lot number: UJ899AA and expiry date: 30-Jun-2023) in unknown administration site for Immunization and on the same day Fluzone Quadrivalent Multidose vial was administered to patient, with no reported adverse event (poor quality product administered)(latency same day) and medication error due to temperature excursion that exceeded the stability data, with no reported adverse event (product storage error) (unknown latency).  Action taken with INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED was not applicable for both events.  At time of reporting, the outcome was Unknown for both events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Administered HPV vaccine, had patient wait for a little while afterwards in chair. Parent said she didn't feel well and then she fainted.
PRESENTED THEMSELVES FOR MODERNA COVID19 VACCINE  ON 07/08/2021 AFTER RECEIVING J&J COVID19 VACCINE ON 03/06/2021
Metallic taste in the mouth for 10-15 minutes post vaccination; started 10 minutes after vaccination.  About 5.5-6 hours after vaccination, experienced rhinorrhea and epiphora for about 1-2 hours, which then progressed to mild nasal congestion and mild chest congestion.  Also experienced mild headache and mild fatigue around the time of the congestion.  Notable puffiness/swelling of the hands and face set in about 10 hours post vaccination; resolved by the next morning upon waking.
Case PHEH2016US027405 is initial spontaneous report received from consumer on 19 Oct 2016. This report refers to unknown demographics patient. Medical history and concomitant medication was not reported. The patient was vaccinated with single dose of FLUCELVAX QUADRIVALENT (batch number and expiry date not reported) intramuscular on an unknown date. On an unspecified date, it was stated that 2 prefilled syringe (PFS) become stuck and the patient did not administered full vaccine amount. The partial vaccine was administered and the patient was revaccinated with a full dose on an unknown date. No adverse event was reported following this medication error (underdose and dose administration).
This spontaneous report as received from a nurse refers to a unspecified number of patients of unknown age. On an unknown date the patient was vaccinated with GARDASIL dose unknown. No concomitant medications were reported. The nurse reported that GARDASIL was exposed to -1.5C for 48 hours and it was administered to unspecified number of patients. No adverse effects were reported. This case is linked to case # 1312USA011848 and 1401USA000288 (same reporter link). Additional information has been requested.
Cloudy eye. Esotropia. Hand flapping. Walking on toes. Change in coordination.